Physician profile
Augustine Njoku
NPI 1174784904
$11,904.47
in general payments reported to CMS, 2019-2025
31 companies · $2,227 in 2025
The $2,227 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $511 · 2020: $285 · 2021: $600 · 2022: $483 · 2023: $717 · 2024: $7,082 · 2025: $2,227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,692 · Food and Beverage: $3,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,692.40 |
| Food and Beverage | $3,333.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,401.94 | 2021-2025 | Symplicity G3, Viance, Abre |
| Abbott Laboratories | $643.37 | 2019-2025 | Dragonfly Opstar, Optis, Cardiomems |
| Novartis Pharmaceuticals Corporation | $642.47 | 2019-2025 | |
| Shockwave Medical, INC | $438.33 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $429.90 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $325.89 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $250.85 | 2019-2023 | Xarelto |
| Pfizer INC. | $211.32 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $199.48 | 2022-2024 | Verquvo |
| Cardiovascular Systems INC. | $188.84 | 2021-2023 | Diamondback Coronary |
| E.R. Squibb & Sons, L.L.C. | $177.95 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $146.96 | 2019-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $119.25 | 2021-2025 | |
| Livanova USA, INC. | $110.18 | 2024 | Protekduo |
| Stryker Corporation | $88.94 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $67.90 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.84 | 2019-2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $56.59 | 2019 | |
| Irhythm Technologies, INC. | $50.63 | 2022-2024 | Zio Monitor, Zio Xt Patch |
| Cvrx, INC. | $47.45 | 2025 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $45.31 | 2024 | |
| Abiomed | $31.06 | 2025 | |
| Terumo Medical Corporation | $30.85 | 2019 | |
| Inspire Medical Systems, INC. | $28.95 | 2024 | Inspire |
| Boston Scientific Corporation | $23.83 | 2020 | |
| Amarin Pharma, INC. | $20.23 | 2020 | |
| Teleflex LLC | $17.65 | 2020 | |
| Vifor Pharma, INC. | $15.41 | 2019 | |
| Philips North America LLC | $14.17 | 2025 | Peripheral Vascular Undivided |
| Surmodics, INC. | $12.93 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Augustine Njoku listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.